WallStreetZenWallStreetZen

NASDAQ: LGND
Ligand Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for LGND

Based on 3 analysts offering 12 month price targets for Ligand Pharmaceuticals Inc.
Min Forecast
$95.00+60.8%
Avg Forecast
$116.33+96.91%
Max Forecast
$144.00+143.74%

Should I buy or sell LGND stock?

Based on 3 analysts offering ratings for Ligand Pharmaceuticals Inc.
Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their LGND stock forecasts and price targets.

LGND stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Bottom 1%
1
BuyReiterates$144.00+143.74%2023-09-19
Benchmark
Bottom 11%
11
Strong BuyReiterates$95.00+60.80%2023-08-23
Barclays
Bottom 14%
14
Strong BuyMaintains$110.00+86.19%2023-07-25

1 of 1

Forecast return on equity

Is LGND forecast to generate an efficient return?
Company
N/A
Industry
11.93%
Market
48.98%

Forecast return on assets

Is LGND forecast to generate an efficient return on assets?
Company
N/A
Industry
1.55%

LGND earnings growth forecast

How is LGND forecast to perform vs Biotechnology companies and vs the US market?
Company
8.92%
Industry
17.24%
Market
66.67%
LGND's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
LGND's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
LGND's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

LGND revenue growth forecast

How is LGND forecast to perform vs Biotechnology companies and vs the US market?
Company
24.35%
Industry
239.17%
Market
11.91%
LGND's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
LGND's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

LGND vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
LGND$59.08$116.33+96.91%Strong Buy
MOR$7.50$12.81+70.84%Strong Buy
RLAY$8.62$25.81+199.45%Buy
APGE$20.87$34.33+64.51%Strong Buy
REPL$16.78$51.20+205.13%Strong Buy
View Top Biotech Stocks

Ligand Pharmaceuticals Stock Forecast FAQ

Is Ligand Pharmaceuticals Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: LGND) stock is to Strong Buy LGND stock.

Out of 3 analysts, 2 (66.67%) are recommending LGND as a Strong Buy, 1 (33.33%) are recommending LGND as a Buy, 0 (0%) are recommending LGND as a Hold, 0 (0%) are recommending LGND as a Sell, and 0 (0%) are recommending LGND as a Strong Sell.

If you're new to stock investing, here's how to buy Ligand Pharmaceuticals stock.

What is LGND's forecast return on equity (ROE) for 2023-2024?

(NASDAQ: LGND) forecast ROE is N/A, which is considered weak.

What is LGND's Price Target?

According to 3 Wall Street analysts that have issued a 1 year LGND price target, the average LGND price target is $116.33, with the highest LGND stock price forecast at $144.00 and the lowest LGND stock price forecast at $95.00.

On average, Wall Street analysts predict that Ligand Pharmaceuticals's share price could reach $116.33 by Sep 19, 2024. The average Ligand Pharmaceuticals stock price prediction forecasts a potential upside of 96.91% from the current LGND share price of $59.08.

What is LGND's forecast return on assets (ROA) for 2023-2024?

(NASDAQ: LGND) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 1.55%.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.